Showing 1 - 20 results of 41 for search 'Gee‐Chen Chang', 查询时间: 0.07s Refine Results
  1. 1
    A novel tool to evaluate and quantify radiation pneumonitis: A retrospective analysis of correlation of dosimetric parameters with volume of pneumonia patch

    A novel tool to evaluate and quantify radiation pneumonitis: A retrospective analysis of correlation of dosimetric parameters with volume of pneumonia patch 由 Jing-Wen Huang, Jing-Wen Huang, Yi-Hui Lin, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Jeremy J. W. Chen

    出版 2023-03-01
    获取全文
    文件
  2. 2
    An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan

    An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan 由 Shang-Gin Wu, Shang-Gin Wu, Chi-Lu Chiang, Chi-Lu Chiang, Chi-Lu Chiang, Chien-Ying Liu, Chin-Chou Wang, Po-Lan Su, Te-Chun Hsia, Jin-Yuan Shih, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang

    出版 2020-09-01
    获取全文
    文件
  3. 3
    Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers

    Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers 由 Sheng-Kai Liang, Sheng-Kai Liang, Li-Hsin Chien, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Ying-Huang Tsai, Wu-Chou Su, Yuh-Min Chen, Ming-Shyan Huang, Hsien-Chih Lin, Wen-Tsen Fang, Hsiao-Han Hung, Shih-Sheng Jiang, Chih-Yi Chen, Kuan-Yu Chen, I-Shou Chang, I-Shou Chang, Chao A. Hsiung, Chien-Jen Chen, Chien-Jen Chen, Pan-Chyr Yang, Pan-Chyr Yang, the GELAC Study Group

    出版 2021-09-01
    获取全文
    文件
  4. 4
    ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies

    ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies 由 Kuo-Tung Tang, Yen-Hsiang Huang, Jeremy J W Chen, Tsung-Ying Yang, Gee-Chen Chang

    出版 2021-04-01
    获取全文
    文件
  5. 5
    Antiplatelet agents and anticoagulants increased the bleeding risk of bedside percutaneous dilational tracheostomy in critically ill patients

    Antiplatelet agents and anticoagulants increased the bleeding risk of bedside percutaneous dilational tracheostomy in critically ill patients 由 Yen-Hsiang Huang, Chien-Hua Tseng, Ming-Cheng Chan, Bor-Jen Lee, Chih-Hung Lin, Gee-Chen Chang

    出版 2020-07-01
    获取全文
    文件
  6. 6
    Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: An open-label single-arm study

    Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: An open-label single-arm study 由 Gee-Chen Chang, Chun-Ming Tsai, Te-Chun Hsia, Chih-Hsin Yang, Radhi Abdulnabi, Julie M. Blair, Carlos Linn

    出版 2013-09-01
    获取全文
    文件
  7. 7
    Exercise experiences in patients with metastatic lung cancer: A qualitative approach.

    Exercise experiences in patients with metastatic lung cancer: A qualitative approach. 由 Pi-Hua Chang, Ching-Rong Lin, Yun-Hsiang Lee, Yi-Lin Liu, Gee-Chen Chang, Aasha I Hoogland, Yeur-Hur Lai

    出版 2020-01-01
    获取全文
    文件
  8. 8
    Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma

    Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma 由 Po-Hsin Lee, Po-Hsin Lee, Po-Hsin Lee, Po-Hsin Lee, Chun-Ju Chiang, Chun-Ju Chiang, Jeng-Sen Tseng, Jeng-Sen Tseng, Jeng-Sen Tseng, Jeng-Sen Tseng, Zhe-Rong Zheng, Zhe-Rong Zheng, Zhe-Rong Zheng, Kun-Chieh Chen, Kun-Chieh Chen, Cheng-Hsiang Chu, Cheng-Hsiang Chu, Yen-Hsiang Huang, Yen-Hsiang Huang, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Wen-Chung Lee, Wen-Chung Lee, Tsung-Ying Yang, Tsung-Ying Yang, Tsang-Wu Liu, Jiun-Yi Hsia, Jiun-Yi Hsia, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang

    出版 2023-02-01
    获取全文
    文件
  9. 9
    Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naïve ALK-positive advanced lung adenocarcinoma

    Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naïve ALK-positive advanced lung adenocarcinoma 由 Zhe-Rong Zheng, Zhe-Rong Zheng, Zhe-Rong Zheng, Hsiu-Ying Ku, Kun-Chieh Chen, Kun-Chieh Chen, Chun-Ju Chiang, Chun-Ju Chiang, Chih-Liang Wang, Chih-Liang Wang, Chih-Yi Chen, Chih-Yi Chen, Chun-Ming Tsai, Ming-Shyan Huang, Ming-Shyan Huang, Ming-Shyan Huang, Chong-Jen Yu, Chong-Jen Yu, Chong-Jen Yu, Jin-Shing Chen, Jin-Shing Chen, Jin-Shing Chen, Teh-Ying Chou, Teh-Ying Chou, Wen-Chung Lee, Wen-Chung Lee, Chun-Chieh Wang, Tsang-Wu Liu, Jiun-Yi Hsia, Jiun-Yi Hsia, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang

    出版 2023-03-01
    获取全文
    文件
  10. 10
    E3 ligase TRIM8 suppresses lung cancer metastasis by targeting MYOF degradation through K48-linked polyubiquitination

    E3 ligase TRIM8 suppresses lung cancer metastasis by targeting MYOF degradation through K48-linked polyubiquitination 由 Chi-Hsuan Wei, Chia-Wei Weng, Chih-Ying Wu, Hsuan-Yu Chen, Ya-Hsuan Chang, Gee-Chen Chang, Jeremy J. W. Chen

    出版 2025-02-01
    获取全文
    文件
  11. 11
    Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced <i>EGFR</i>-Mutant Lung Adenocarcinoma

    Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced <i>EGFR</i>-Mutant Lung Adenocarcinoma 由 Po-Hsin Lee, Yen-Hsiang Huang, Ho Lin, Kuo-Hsuan Hsu, Kun-Chieh Chen, Jeng-Sen Tseng, Gee-Chen Chang, Tsung-Ying Yang

    出版 2022-07-01
    获取全文
    文件
  12. 12
    Real-world clinical efficacy of bevacizumab biosimilar in patients with advanced non-small-cell lung cancer

    Real-world clinical efficacy of bevacizumab biosimilar in patients with advanced non-small-cell lung cancer 由 Wei-Fan Ou, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Po-Hsin Lee, Kun-Chieh Chen, Yen-Hsiang Huang, Gee-Chen Chang, Tsung-Ying Yang

    出版 2024-10-01
    获取全文
    文件
  13. 13
    Pemetrexed induces S-phase arrest and apoptosis via a deregulated activation of Akt signaling pathway.

    Pemetrexed induces S-phase arrest and apoptosis via a deregulated activation of Akt signaling pathway. 由 Kun-Chieh Chen, Tsung-Ying Yang, Chun-Chi Wu, Chi-Chih Cheng, Shih-Lan Hsu, Hsiao-Wen Hung, Jian-Wei Chen, Gee-Chen Chang

    出版 2014-01-01
    获取全文
    文件
  14. 14
    Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer.

    Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer. 由 Sheng-Yi Lin, Hsiu-Hui Chang, Yi-Hua Lai, Ching-Hsiung Lin, Min-Hsuan Chen, Gee-Chen Chang, Meng-Feng Tsai, Jeremy J W Chen

    出版 2015-01-01
    获取全文
    文件
  15. 15
    Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer

    Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer 由 Jin-Yuan Shih, Yung-Hung Luo, Gee-Chen Chang, John Wen-Cheng Chang, Chin-Chou Wang, Tsung-Ying Yang, Wei-Tse Fang, Wen-Yi Shau

    出版 2024-08-01
    获取全文
    文件
  16. 16
    Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy.

    Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy. 由 Jen-Yi Lee, Yee-Ming Lee, Gee-Chen Chang, Sung-Liang Yu, Wan-Yu Hsieh, Jeremy J W Chen, Huei-Wen Chen, Pan-Chyr Yang

    出版 2011-01-01
    获取全文
    文件
  17. 17
    JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer.

    JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer. 由 Wen-Hsin Chang, Bing-Ching Ho, Yi-Jing Hsiao, Jin-Shing Chen, Chien-Hung Yeh, Hsuan-Yu Chen, Gee-Chen Chang, Kang-Yi Su, Sung-Liang Yu

    出版 2016-01-01
    获取全文
    文件
  18. 18
    Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma.

    Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma. 由 Kang-Yi Su, Jeng-Sen Tseng, Keng-Mao Liao, Tsung-Ying Yang, Kun-Chieh Chen, Kuo-Hsuan Hsu, Pan-Chyr Yang, Sung-Liang Yu, Gee-Chen Chang

    出版 2018-01-01
    获取全文
    文件
  19. 19
    Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects

    Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects 由 Yi-Jing Hsiao, Min-Shu Hsieh, Gee-Chen Chang, Yin-Chen Hsu, Chia-Yu Wang, Yan-Ming Chen, Yi-Ling Chen, Pan-Chyr Yang, Sung-Liang Yu

    出版 2025-01-01
    获取全文
    文件
  20. 20
    Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors

    Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors 由 Po-Hsin Lee, Tsung-Ying Yang, Kun-Chieh Chen, Yen-Hsiang Huang, Jeng-Sen Tseng, Kuo-Hsuan Hsu, Yu-Chen Wu, Ko-Jiunn Liu, Gee-Chen Chang

    出版 2021-04-01
    获取全文
    文件

检索工具: